GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Serina Therapeutics Inc (AMEX:SER) » Definitions » Inventories, Raw Materials & Components

SER (Serina Therapeutics) Inventories, Raw Materials & Components : $0.00 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Serina Therapeutics Inventories, Raw Materials & Components?

Serina Therapeutics's inventories, raw materials & components for the quarter that ended in Dec. 2024 was $0.00 Mil.


Serina Therapeutics Inventories, Raw Materials & Components Historical Data

The historical data trend for Serina Therapeutics's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Serina Therapeutics Inventories, Raw Materials & Components Chart

Serina Therapeutics Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Inventories, Raw Materials & Components
- - - -

Serina Therapeutics Quarterly Data
Dec21 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Serina Therapeutics Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.


Serina Therapeutics Business Description

Industry
Traded in Other Exchanges
Address
601 Genome Way, Suite 2001, Huntsville, AL, USA, 35806
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.